Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

Banach, MaciejLewek, JoannaPol, KajaRabczenko, DanielBalanescu, Serban M.Blaha, VladimirCeska, RichardJankowski, PiotrSurma, StanisawKolovou, GenovefaLiberopoulos, EvangelosMitu, FlorinMitu, MagdaNaji, Franjo HusamParagh, GyörgyPopawska, MagdalenaVrablík, MichalPella, Daniel2023-11-142023-11-142023Frontiers in Cardiovascular Medicine. -10 (2023), p. 1-9. -Front. Cardiovasc. Med. - 2297-055X. - 2297-055X2297-055Xhttps://hdl.handle.net/2437/360630Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE studyfolyóiratcikkopen access journalhttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM116102OrvostudományokKlinikai orvostudományokhttps://www.frontiersin.org/articles/10.3389/fcvm.2023.1206551/fullszerzőhttp://dx.doi.org/10.3389/fcvm.2023.12065512023-11-1400101781540000185164401622